NIH Grants Selux Diagnostics $2.8 Million for Rapid AST Platform
The NIH awarded Selux a $2.8 million grant for commercialization of its Next Generation Phenotyping platform for rapid antimicrobial susceptibility testing.
Read MorePosted by Chris Wolski | Oct 20, 2021 | Diagnostic Technologies |
The NIH awarded Selux a $2.8 million grant for commercialization of its Next Generation Phenotyping platform for rapid antimicrobial susceptibility testing.
Read MorePosted by Chris Wolski | Oct 18, 2021 | Breast, Prostate |
Roche has entered an agreement with Ibex Medical Analytics, a provider of artificial intelligence (AI)-based cancer diagnostics.
Read MorePosted by Chris Wolski | Oct 14, 2021 | Molecular Diagnostics |
Caris Life Sciences and Ono Pharmaceutical Co., Ltd.have announced a strategic collaboration to leverage Caris’ molecular profiling.
Read MorePosted by Chris Wolski | Oct 14, 2021 | Anatomic Pathology |
Scientists have developed a novel all-fiber based endoscopic set up to record tissue images displaying both morphological and biochemical information.
Read MorePosted by Chris Wolski | Oct 12, 2021 | Cervical (HPV), Cytology |
Researchers have found that many women are screened for cervical cancer too often, while others are not getting tested often enough.
Read More